Sujita Sukumaran, Ph.D.
About Sujita Sukumaran, Ph.D.
Sujita Sukumaran, Ph.D., is a scientist with over 10 years of research experience in both academia and industry, specializing in T cell-based therapies and immunotherapy. Currently, she works as a Senior Scientist at Instil Bio and as a Scientist at Kite Pharma, focusing on the preclinical development of novel therapeutic strategies.
Work at Kite Pharma
Sujita Sukumaran has been employed at Kite Pharma as a Scientist since 2018. In this role, she focuses on advancing the development of innovative therapies in the field of oncology. Kite Pharma is known for its commitment to developing transformative cell therapies for cancer treatment, particularly through CAR T cell therapy. Sukumaran's expertise in T cell biology and immunotherapy contributes to the company's mission of improving patient outcomes.
Current Role at Instil Bio
Sujita Sukumaran currently serves as a Senior Scientist at Instil Bio, a position she has held since 2020. In this capacity, she engages in research aimed at enhancing T cell-based therapies. Her work at Instil Bio aligns with her passion for preclinical development and testing of novel strategies, particularly in the context of immunotherapy and adoptive T cell therapy.
Education and Expertise
Sujita Sukumaran holds a Ph.D. in Translational Biology and Molecular Medicine from Baylor College of Medicine, which she completed between 2012 and 2018. Prior to her doctoral studies, she earned a Master's degree in Biology from Texas A&M University from 2006 to 2008 and a Bachelor's degree in Biology from Birla Institute of Technology and Science, Pilani from 2002 to 2006. Her educational background equips her with a robust understanding of cell and molecular biology, immuno-oncology, and gene therapy.
Research Experience
Sujita Sukumaran has over 10 years of research experience in both academic and industrial settings. Her career includes roles such as Graduate Student Researcher at Texas A&M University and Research Associate at ApoCell Biosciences. She has also worked as an Undergraduate Research Assistant at Birla Institute of Technology and Science, Pilani. Throughout her career, she has trained, mentored, and supervised numerous students and research technicians, contributing to the development of future scientists.
Specialization in T Cell Therapies
Sujita Sukumaran specializes in various aspects of T cell therapies, including adoptive T cell therapy and CAR T cell therapy. Her expertise encompasses a wide range of scientific techniques related to T cell biology, immunotherapy, and microscopy. This specialization positions her as a knowledgeable contributor to the field of immuno-oncology, where she focuses on developing novel strategies to enhance the efficacy of T cell-based treatments.